| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Alogliptin |
| Brand | Vipidia® |
| Indication | For adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control. |
| Assessment Process | |
| Rapid review commissioned | 27/09/2013 |
| Rapid review completed | 30/10/2013 |
| Rapid review outcome | Full HTA not recommended |